The nurse is caring for a patient who is being treated for idiopathic thrombocytopenic purpura (ITP). Which treatment will the nurse administer as part of this patient's management?

Choice A reason: Normal blood pressure and deep respirations do not necessarily indicate that hyperosmolar hyperglycemic syndrome is resolving. Deep respirations, also known as Kussmaul respirations, can occur in response to severe hyperglycemia.

Choice B reason: Increased alertness and a normal heart rhythm suggest that the patient's neurological status and cardiovascular system are stabilizing, which are positive indicators that the treatment is effective in managing hyperosmolar hyperglycemic syndrome.

Choice C reason: High urine specific gravity and normal temperature do not directly indicate the effectiveness of treatment for hyperosmolar hyperglycemic syndrome. High urine specific gravity can result from dehydration.

Choice D reason: A blood glucose level of 250 mg/dL with disorientation still indicates poorly controlled hyperglycemia and ongoing metabolic disturbance, which means the treatment is not yet effective.

Choice A reason: Platelet transfusions are typically reserved for patients with severe bleeding or extremely low platelet counts. They are not a standard treatment for managing ITP unless there is significant bleeding.

Choice B reason: Plasma albumin is not a treatment for ITP. It is used for other conditions such as hypovolemia and hypoalbuminemia but does not address the underlying immune-mediated destruction of platelets in ITP.

Choice C reason: Intravenous immunoglobulin (IVIG) is a treatment for ITP that helps increase platelet counts by modulating the immune system. It is often used in acute settings to manage severe thrombocytopenia and bleeding.

Choice D reason: Factor D is not related to the treatment of ITP. It is involved in the complement system, which is part of the immune response but does not directly address the platelet destruction seen in ITP.